Keywords
cerebrospinal fluid
varieties Cryptococcus neoformans
AIDS
How to Cite
Abstract
Cryptococcus neoformans is an encapsulated yeast that presents tropism for central nervous system, and causes meningoencephalitis. Cryptococcosis is the most frequent mycosis in patients with AIDS, and it is the cause of high morbidity and mortality. C. neoformans presents two varieties var. neoformans and var. gattii. Cryptococcus neoformans var. neoformans has been world-wide isolated from avian feces, especially pigeon excreta. C. neoformans var. gattii is geographically restricted to tropical and subtropical regions, and it is associated with some trees species, mainly Eucalyptus sp. The proposal of this study was to evaluate the prevalence of Cryptococcus neoformans varieties isolated from 452 cerebrospinal fluid (CSF) samples from 183 patients with AIDS referred to the Instituto de Infectologia Emilio Ribas - Sao Paulo-SP, from 1996 to 1999. CSF samples were cultured on canavanine-glycine-bromothymol blue medium. Of 452 samples, C. neoformans var. neoformans was isolated in 446 (98.7%), and C. neoformans var. gattii. in 6 (1.3%) samples.References
1. Severo LC, Oliveira FM, Londero AT. Cryptococcosis dueto Cryptococcus neoformans var. gattii in Brazilian patients with AIDS. Report of the three cases. Rev Iberoam Micol1999; 16: 152-4.
2. Kwon-Chung KJ, Bennett JE. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE. Medical Mycology. Lea & Febiger, Philadelphia PA, 1992. p.397-446.
3. Richardson MD, Warnock DW. Cryptococcosis. In: Fungal Infection: Diagnosis and Management. Blackwell Science, 2Th edition, Oxford UK, 1998. p.149-59.
4. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) andCryptococcus neoformans var. gattii (serotypes B and C).J Clin Microbiol 1982; 15: 535-7.
5. Ikeda R, Shinoda T, Fukazawa Y, Kaufman L. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J ClinMicrobiol 1982; 16: 22-9.
6. Ikeda R, Nishikawa A, Shinoda T, Fukazawa Y. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D. Microbiol Immunol 1985; 29: 981-91.
7. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietals status forserotype A isolates. J Clin Microbiol 1999; 37: 838-40.
8. Casadevall A, Perfect JR. Cryptococcus neoformans.American Society for Microbiology, Washington DC,1998. 540p.
9. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans.Clin Microbiol Rev 1995; 8: 515-48.
10. Sorrell TC, Ellis DH. Ecology of Cryptococcus neoformans. Rev Iberoam Micol 1997; 14: 42-3.
11. Machado CC, amaral AA, Severo LC. Cryptococcus neoformans var. neoformans isolado do solo. Rev Inst Med Trop São Paulo 1993; 1: 77-9.
12. Ellis DH, Pfeiffer J. Natural habitat of Cryptococcus neo formans variety gattii. J Clin Microbiol 1990;28: 1693-4.
13. Sorrell TC, Chen SC, Ruma P, Meyer W, Pfeiffer TJ, Ellis DH, Brownlee AG. Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J Clin Microbiol 1996; 34: 1253-60.
14. Lazera MS, Cavalcanti MAS, Trilles L, Nishikawa MM, Wanke B. Cryptococcus neoformans var. gattii – evidence for a natural habitat related to decaying wood in a pottery tree hollow. J Med Vet Mycol 1998; 36: 119-22.
15. Lazera M, Cavalcanti MAS, Londero AT, Trilles L, Nishikawa MM, Wanke B. Possible primary ecological niche of Cryptococcus neoformans. Med Mycol 2000;38: 379-83.
16. Fortes ST, Lazera MS, Nishikawa MM, Macedo RC, Wanke B. First isolation of Cryptococcus neoofrmans var. gattii from a native jungle tree in the Brazilian Amazon rainforest. Mycoses 2001; 44: 137-40.
17. Callejas A, Ordoñez N, Rodriguez MC,Castaneda E. First isolation of Cryptococcus neoformans var. gattii, serotype C, from the environment in Colômbia. Med Mycol 1998;36: 341-4.
18. Brasil. Ministério da Saúde. Programa Nacional de Doenças Sexualmente Transmissíveis. Bol Epidemiol AIDS. Brasilia/DF,1999. p. 44.
19. Pappalardo MC, Melhem MS. Cryptococcosis: a reviewof the Brazilian experience for the disease. Rev Inst Med Trop Sao Paulo 2003; 45: 299-305.
20. Silva MT, Araujo A. Highly active antiretroviral therapyaccess and neurological complications of human immunodeficiency virus infection: Impact versus resourcesin Brazil. J Neurovirol 2005; 11: 11-5.
21. Rozenbaum R, Gonçalves AJR. Clinical and epidemiological study of 171 cases of cryptococcosis. ClinInf Dis 1994; 18: 369-80.
22. Montenegro H, Paula CR. Environmental isolation of Cryptococcus neoformans var. gattii and C. neo formansvar. neoformans in the city of São Paulo, Brazil. MédMycol 2000; 38: 385-90.
23. Lacaz CS, Rodrigues MC. Sorotipagem de Cryptococcus neoformans. Rev BrasMed 1983; 40: 297-300.
24. Rozenbaum R. Criptococose. Contribuição ao estudo da micose e de seu agente no Brasil. [Tese de Mestrado]. Faculdade de Medicina da Universidade Federal do Rio de Janeiro-UFRJ, Rio de Janeiro, 1990.
25. Rozembaum R, Gonçalves ARJ, Wanke B, Caiuby MJ, Clemente H, Lazera MSet al. Cryptococcus neo formans varieties as agent of cryptococcosis in Brazil. Mycopathologia 1992; 119: 133-6.
26. Morales BMC. Avaliação dos perfis de susceptibilidade a antifúngicos e cariotipagem eletroforética de isolados clínicos de Cryptococcus neoformans, do Brasil, Chile e Venezuela, segundo variedades e sorotipos. [Tese dedoutorado]. Universidade Federal de São Paulo-UNIFESP,São Paulo, 1999.
27. Calvo BM, Colombo AL, Fischman O, Santiago A,Thompson L, Lazera MS et al. Antifungal susceptibilities,varieties, and electrophoretic karyotypes of clinical isolatesof Cryptococcus neoformans from Brazil, Chile, and Venezuela. J Clin Microbiol 2001; 39: 2348-50.
28. Fernandes OFL, Costa TR, CostaMR, Soares AJ, Pereira AJSC, Silva MRR. Cryptococcus neoformans isolados de pacientes com AIDS. Rev Soc Bras Med Trop 2000;33: 75-8.
29. Martins MA, Melhem MSC, Pukinskas SRBS, Cabrera MI, Soares MCB, Meira MCA et al. Variedades de cepas clínicas de Cryptococcus neoformans no Estado de SãoPaulo: dez anos de estudo multicêntrico. Rev Inst Adolfo Lutz 2003; 62 (Suppl 2): 12.
30. Nishikawa MM, Lazera MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RCL et al. Serotyping of 467 Cryptococcus neoformans isolates from clinical andenvironmental sources in Brazil: analysis of host andregional patterns. J Clin Microbiol 2003; 41: 73-7.
31. Kwon-Chung KJ. Cryptococcus. In: Kurtzman CP, FellJW. The yeasts: a taxonomic study. Elsevier B.V. 4Thedition, Amsterdam, 1998. p. 656-62.
32. Chen SCA, Brownlee AG, Sorrell TC, Ruma P, Nimmo G. Identification by random amplification of polymorphic DNAof a common molecular type of Cryptococcus neoformansvar neoformans in patients with Aids or otherimmunosupressive conditions. J Infec Dis 1996; 173: 754-8.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2007 Instituto Adolfo Lutz Journal